IDEXX Reference Laboratories
IDEXX FGF-23 Test
A new method for managing and monitoring phosphorous overload in chronic kidney disease—now included in IRIS treatment recommendations for CKD in cats.
Early detection of phosphorous overload and metabolic bone disease in cats with IRIS CKD Stage 1 and Stage 21,2
Enables confident treatment recommendations, such as introducing a phosphate-restrictive diet
Enhanced view of a patient's kidney health — as an addition to IDEXX's suite of kidney health diagnostics, including the IDEXX SDMA Test
Diagnostic update: IDEXX FGF-23 Test
International Renal Interest Society (IRIS) Treatment Recommendations for CKD in Cats
New Insights into Phosphate Homeostasis in Feline Early CKD: The Role of Fibroblast Growth Factor 23
- Geddes RF, Elliott J, Syme HM. Relationship between Plasma Fibroblast Growth Factor-23 concentration and Survival Time in Cats with Chronic Kidney Disease. J Vet Intern Med. 2015;29:1494-1501.
- Finch NC, Geddes RF, Syme HM, Elliott J. Fibroblast Growth Factor 23 (FGF-23) Concentrations in Cats with Early Nonazotemic Chronic Kidney Disease (CKD) and in Health Geriatric Cats. J Vet Intern Med. 2013;27:227-233